Advanced medical devices and regulatory innovations in new health technology assessments
10.5124/jkma.2018.61.12.702
- Author:
You Kyoung LEE
1
Author Information
1. Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea. cecilia@schmc.ac.kr
- Publication Type:Editorial
- Keywords:
Technology assessment, biomedical;
Advanced medical device;
Patient safety;
Coverage with evidence development;
Regulatory innovation
- MeSH:
Biomedical Technology;
Delivery of Health Care;
Diagnosis;
Ecosystem;
Health Care Sector;
Humans;
Insurance Carriers;
Korea;
Patient Safety;
Rabbits;
Technology Assessment, Biomedical;
Uncertainty
- From:Journal of the Korean Medical Association
2018;61(12):702-705
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Advances in technology lead to advances in medical devices, and these advances have the positive effect of creating opportunities for beneficial developments in healthcare, such as innovating traditional healthcare processes or expanding opportunities for diagnosing and treating diseases. Nonetheless, device developers, suppliers, users, insurers, and patients all face the challenge of balancing patient safety and health effectiveness with a reasonable profit. In Korea, the New Health Technology Assessment system aims to introduce safe and effective health technology, but this is only effective for the entry of devices onto the healthcare market. This system is not enough for creating a healthy ecosystem in which high-quality technologies and devices survive in the market and naturally exit from the market if not successful. The nation must not lag in the rapid development of medical devices, but the concomitant requirement for patient safety is like two rabbits moving in different directions. There is not enough time to resolve each source of uncertainty for both developers and users. The early adoption of health technologies, including medical devices, offers new opportunities for treatment and diagnosis, but also poses unexpected health risks. Thus, we need to design a plan to generate scientific evidence related to medical devices after they introduced into practice. Additionally, regarding the use of individual medical devices, we believe that the creation of a healthy ecosystem for medical devices by implementing medical device surveillance culture is a way to manage the opportunities and risks of the early introduction of innovative medical devices.
